Scientists leveraged an enzyme that is part of the protein-making machinery--called Ded1p. Mutations in the human version of Ded1p are linked to tumors and cognitive disabilities.

TOP INSIGHT
A mechanism that explains how sites are chosen for translation events that occur in regions that are traditionally considered untranslated and that initiate at non-traditional start sites has been discovered.
"Over the last several years it has become clear that translation in these regions is pervasive, but it is poorly understood how start sites are chosen among the millions of possible start sites," said senior author Eckhard Jankowsky, PhD, professor in the Center for RNA Molecular Biology at Case Western Reserve University School of Medicine.
Viruses often target the critical enzyme to disrupt protein synthesis inside cells. Jankowsky's team created yeast cells with defective Ded1p. The use of alternative start sites for protein synthesis, like AUA or AAG, dramatically increased in these cells. However, the cells only used a small fraction of possible alternative sites.
The researchers found that chosen alternative start sites were next to regions where the RNA folds back on itself. Ded1p is an RNA helicase--an enzyme that unzips folded RNA structures--but if it is defective it is unable to do so. If left folded, RNA structures stall scanning by the protein-making machinery and cause protein synthesis from an alternative start site nearby. "Our findings reveal a simple mechanism that involves RNA structure and a helicase." Jankowsky said. "If an alternative initiation site is close to RNA structure, it is used to start protein synthesis. So RNA structure and alternative initiation sites together are the signal to start protein production from non-traditional sites."
Since Ded1p is present in all organisms, the findings are likely universally applicable. Protein synthesis starting from alternative translation initiation sites often impacts production of main proteins, encoded after AUG strings in the RNA, and thereby determines protein balance inside cells.
MEDINDIA




Email






